| 000 | 01334 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517192153.0 | ||
| 264 | 0 | _c20180222 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1744-7607 | ||
| 024 | 7 |
_a10.1080/17425255.2018.1420162 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGalluzzo, M | |
| 245 | 0 | 0 |
_aPharmacokinetic drug evaluation of dalbavancin for the treatment of skin infections. _h[electronic resource] |
| 260 |
_bExpert opinion on drug metabolism & toxicology _cFeb 2018 |
||
| 300 |
_a197-206 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCost Savings |
| 650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHospitalization _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLength of Stay |
| 650 | 0 | 4 |
_aSkin Diseases, Bacterial _xdrug therapy |
| 650 | 0 | 4 |
_aTeicoplanin _xadministration & dosage |
| 650 | 0 | 4 |
_aVancomycin _xtherapeutic use |
| 700 | 1 | _aD'Adamio, S | |
| 700 | 1 | _aBianchi, L | |
| 700 | 1 | _aTalamonti, M | |
| 773 | 0 |
_tExpert opinion on drug metabolism & toxicology _gvol. 14 _gno. 2 _gp. 197-206 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/17425255.2018.1420162 _zAvailable from publisher's website |
| 999 |
_c27906425 _d27906425 |
||